4//SEC Filing
Cole G Bradley 4
Accession 0001415889-25-015805
CIK 0001730430other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 5:07 PM ET
Size
11.9 KB
Accession
0001415889-25-015805
Insider Transaction Report
Form 4
Cole G Bradley
Director
Transactions
- Exercise/Conversion
Class A Ordinary Share
2025-06-05+3,173→ 12,546 total - Award
Restricted Share Units
2025-06-03+2,799→ 2,799 total→ Class A Ordinary Shares (2,799 underlying) - Award
Share Option
2025-06-03+16,798→ 16,798 totalExercise: $29.11Exp: 2035-06-02→ Class A Ordinary Shares (16,798 underlying) - Exercise/Conversion
Restricted Share Units
2025-06-05−3,173→ 0 total→ Class A Ordinary Shares (3,173 underlying)
Footnotes (4)
- [F1]Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.
- [F2]The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant with the final installment vesting on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is June 3, 2025.
- [F3]The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is June 3, 2025.
- [F4]The RSUs vested in a single installment on June 5, 2025; there was no expiration date for the RSUs.
Documents
Issuer
Kiniksa Pharmaceuticals International, plc
CIK 0001730430
Entity typeother
Related Parties
1- filerCIK 0001337798
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 5:07 PM ET
- Size
- 11.9 KB